Companies: 10,795·Total market cap: $144.5T
Artemis Therapeutics Inc.

Artemis Therapeutics Inc.

ATMSOTCFinancial Services
$0.50
$-1.39(-73.65%)
Market Cap$55792932
P/E Ratio
52W High$4.5
52W Low$0.1121
Overview

Artemis Therapeutics Inc.(ATMS)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · ATMS · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income
Breakdown2022-122021-122020-122019-122018-12
Revenue
Revenue$0.31M$0.00M$0.00M$0.00M$0.26M
Cost of Revenue$0.05M$0.00M$0.00M$0.00M$0.00M
Gross Profit$0.26M$0.00M$0.00M$0.00M$0.26M
Gross Margin %(computed)82.64%100.00%
Operating Expenses
R&D Expenses$0.00M$0.00M$0.00M$0.00M$0.25M
G&A Expenses$0.95M$0.15M$0.17M$0.17M$0.53M
Total Operating Expenses$1.62M$0.15M$0.17M$0.17M$0.77M
Operating Income($1.36M)($0.15M)($0.17M)($0.17M)($0.77M)
Operating Margin %(computed)-436.98%-298.07%
Interest Income$0.00M$0.00M$0.00M$0.00M$0.26M
Interest Expense$0.00M$0.01M$0.01M$0.01M$0.00M
Income Before Tax($1.35M)($0.17M)($0.17M)($0.17M)($0.51M)
Income Tax Expense($0.00M)$0.01M($0.05M)($0.05M)$0.00M
Net Income($1.35M)($0.18M)($0.12M)($0.12M)$0.51M
Net Margin %(computed)-434.41%198.07%
Per Share & EBITDA
EPS (Basic)$-0.01$-0.01$-0.02$-0.02$-0.10
Wtd Avg Shares57058.28M26.14M5.15M5.15M5.15M
EBITDA($1.34M)($0.15M)($0.17M)($0.17M)($0.51M)
EBITDA Margin %(computed)-431.83%-198.07%

数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · USD · M

深入了解Artemis Therapeutics Inc.

关于Artemis Therapeutics Inc.(ATMS)损益表

Artemis Therapeutics Inc.(ATMS)损益表数据来源于SEC Form 10-K及10-Q申报文件。2022财年,ATMS实现营收$0.00B,毛利润$0.00B(毛利率82.64%),净利润($0.00B)(净利率-434.41%)。

常见问题

ATMS · 4 问

Artemis Therapeutics Inc.(ATMS)2022财年营收为$0.00B,同比up—%。

ATMS revenueATMS salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09